Evergreen Capital Management’s Boston Scientific BSX Stock Holding History

Evergreen Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.37M	Buy	21,853 +6,320	+41%	+$506K	0.03%	401
2025 Q4	$1.48M	Buy	15,533 +6,736	+77%	+$660K	0.03%	374
2025 Q3	$859K	Buy	8,797 +929	+12%	+$96.2K	0.02%	447
2025 Q2	$845K	Buy	7,868 +327	+4%	+$33.1K	0.03%	401
2025 Q1	$761K	Buy	7,541 +1,210	+19%	+$122K	0.03%	383
2024 Q4	$565K	Buy	6,331 +106	+2%	+$9.33K	0.02%	465
2024 Q3	$522K	Buy	6,225 +275	+5%	+$21.7K	0.02%	484
2024 Q2	$458K	Buy	5,950 +1,315	+28%	+$96.3K	0.02%	495
2024 Q1	$317K	Buy	4,635 +249	+6%	+$16K	0.01%	602
2023 Q4	$254K	Buy	4,386 +176	+4%	+$9.39K	0.01%	670
2023 Q3	$222K	Sell	4,210 -180	-4%	-$9.44K	0.01%	666
2023 Q2	$237K	Buy	+4,390	New	+$229K	0.01%	652

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Evergreen Capital Management's BSX Position: Q1 2026 in Review

Evergreen Capital Management increased its Boston Scientific (BSX) stake by 41% in Q1 2026, buying an estimated $506K and bringing the position to 21,853 shares worth $1.37M. The position accounts for 0.03% of the portfolio, ranked #401.

Evergreen Capital Management first reported a position in BSX in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.48M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Evergreen Capital Management held 21,853 shares of Boston Scientific worth $1.37M as of Q1 2026.
Evergreen Capital Management bought 6,320 Boston Scientific shares in Q1 2026, an estimated $506K.
Boston Scientific made up 0.03% of Evergreen Capital Management's portfolio in Q1 2026, its #401 holding.
Evergreen Capital Management first reported a position in Boston Scientific in Q2 2023 and has held it in 12 quarters since.
Evergreen Capital Management's Boston Scientific position peaked at $1.48M in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Evergreen Capital Management's 13F filing for Q1 2026, filed 14 May 2026.